Treatment and Physiology in Parkinson’s Disease and Dystonia: Using Transcranial Magnetic Stimulation to Uncover the Mechanisms of Action
- 586 Downloads
Transcranial magnetic stimulation (TMS) has served as an important technological breakthrough in the field of the physiology of movement disorders over the last three decades. TMS has grown popular owing to the ease of application as well as its painless and noninvasive character. The technique has provide important insights into understanding the pathophysiology of movement disorders, particularly Parkinson’s disease and dystonia. The basic applications have included the study of motor cortex excitability, functioning of excitatory and inhibitory circuits, study of interactions between sensory and motor systems, and the plasticity response of the brain. TMS has also made important contributions to understanding the response to treatments such as dopaminergic medications, botulinum toxin injections, and deep brain stimulation surgery. This review summarizes the knowledge gained to date with TMS in Parkinson’s disease and dystonia, and highlights the current challenges in the use of TMS technology.
KeywordsTranscranial magnetic stimulation Parkinson’s disease Dystonia
This work was supported by the University of Florida, Clinical and Translation Science Institute sponsored NIH KL2 TR000065 (Aparna Wagle Shukla), NIH R01 NS052318 (David E. Vaillancourt), and R01 NS075012 (David E. Vaillancourt), the Bachmann-Straus Dystonia & Parkinson Foundation (David E. Vaillancourt) and Tyler’s Hope Foundation (David E. Vaillancourt).
Compliance with Ethics Guidelines
Conflict of Interest
AparnaWagle Shukla has pending (not pending) but received grants from the Clinical and Translation Science Institute CTSI (KL2) and the Dystonia Coalition, Dystonia Medical Research Foundation.
David E. Vaillancourt has received an NIH grant (R01 NS52318, R01 NS58487) and a grant from the Bachmann-Strauss Dystonia & Parkinson Foundation and Tyler’s Hope Foundation. He has also received board membership payments as an NIH study section member and consultancy fees from the University of Texas Southwestern Medical School and the University of Illinois at Chicago. He has also received honoraria from the University of Colorado and the University of Pittsburgh.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 15.Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson’s disease and drug-induced parkinsonism. Brain. 1994;117(2):317–23.PubMedGoogle Scholar
- 46.•Kishore A, Popa T, Velayudhan B, Joseph T, Balachandran A, Meunier S. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson’s disease. Brain. 2012;135(7):2074–88. Kishore et al. used a TMS-based plasticity protocol in their study of PD patients. They found levodopa challenge worsens LTD-like plasticity and worsens LTP-like plasticity in nondyskinetic motor fluctuators.PubMedGoogle Scholar
- 50.•Wagle Shukla A, Moro E, Gunraj C, Lozano A, Hodaie M, Lang A, et al. Long-term subthalamic nucleus stimulation improves sensorimotor integration and proprioception. J Neurol Neurosurg Psychiatry. 2013;84(9):1020–8. Wagle Shukla et al. conducted a longitudinal study in PD patients and found that chronic STN DBS is required to correct the abnormal sensorimotor integration.PubMedGoogle Scholar
- 51.•Kojovic M, Caronni A, Bologna M, Rothwell JC, Bhatia KP, Edwards MJ. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Mov Disord. 2011;26(7):1282–9. Kojovic et al. found SICI is corrected and the PAS effect is reduced at the peak dose effects of botulinum toxin injections in patients with dystonia.PubMedCentralPubMedGoogle Scholar
- 52.•Ruge D, Tisch S, Hariz MI, Zrinzo L, Bhatia KP, Quinn NP, et al. Deep brain stimulation effects in dystonia: time course of electrophysiological changes in early treatment. Mov Disord. 2011;26(10):1913–21. Ruge et al. examined dystonia patients who underwent bilateral GPi DBS surgery. They used TMS to find abnormalities in the inhibitory circuit (SICI) are corrected at 1 month; however, at 6 months after GPi DBS surgery, the plasticity response, which is abnormally enhanced in dystonia, becomes reduced.PubMedCentralPubMedGoogle Scholar
- 94.Wiegand H, Erdmann G, Wellhoner HH. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedeberg’s Arch Pharmacol. 1976;292(2):161–5.Google Scholar